Attachments
Share price & Turnover
0.00%
|
0.26 MSEK
Share price change and turnover during the day of this press release
Calendar
2025-02-21 | Year-end Report 2024 |
2024-11-06 | Quarterly Report 2024-Q3 |
2024-08-15 | Quarterly Report 2024-Q2 |
2024-05-22 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2024-05-21 | Annual General meeting |
2024-05-07 | Quarterly Report 2024-Q1 |
2024-02-23 | Year-end Report 2023 |
2024-01-11 | Extra General Meeting 2023 |
2023-10-24 | Quarterly Report 2023-Q3 |
2023-08-11 | Quarterly Report 2023-Q2 |
2023-04-24 | Quarterly Report 2023-Q1 |
2023-04-21 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2023-04-20 | Annual General meeting |
2023-02-24 | Year-end Report 2022 |
2023-01-09 | Extra General Meeting 2022 |
2022-11-10 | Quarterly Report 2022-Q3 |
2022-08-18 | Quarterly Report 2022-Q2 |
2022-05-25 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2022-05-24 | Annual General meeting |
2022-05-12 | Quarterly Report 2022-Q1 |
2022-02-25 | Year-end Report 2021 |
2021-12-16 | Extra General Meeting 2021 |
2021-11-10 | Quarterly Report 2021-Q3 |
2021-08-18 | Quarterly Report 2021-Q2 |
2021-06-10 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2021-05-27 | Annual General meeting |
2021-05-12 | Quarterly Report 2021-Q1 |
2021-02-26 | Year-end Report 2020 |
2020-11-10 | Quarterly Report 2020-Q3 |
2020-08-17 | Quarterly Report 2020-Q2 |
2020-07-28 | Extra General Meeting 2020 |
2020-06-30 | Annual General meeting |
2020-06-17 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2020-05-14 | Quarterly Report 2020-Q1 |
2020-02-27 | Year-end Report 2019 |
2019-11-08 | Quarterly Report 2019-Q3 |
2019-08-16 | Quarterly Report 2019-Q2 |
2019-06-20 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2019-06-19 | Annual General meeting |
2019-05-15 | Quarterly Report 2019-Q1 |
2019-02-27 | Year-end Report 2018 |
2018-11-09 | Quarterly Report 2018-Q3 |
2018-08-17 | Quarterly Report 2018-Q2 |
2018-05-15 | Quarterly Report 2018-Q1 |
2018-03-29 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2018-03-28 | Annual General meeting |
2018-02-27 | Year-end Report 2017 |
2017-11-09 | Quarterly Report 2017-Q3 |
2017-08-17 | Quarterly Report 2017-Q2 |
2017-05-19 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2017-05-18 | Annual General meeting |
2017-05-16 | Quarterly Report 2017-Q1 |
2017-02-27 | Year-end Report 2016 |
2016-11-10 | Quarterly Report 2016-Q3 |
2016-08-17 | Quarterly Report 2016-Q2 |
2016-07-22 | Extra General Meeting 2016 |
2016-05-20 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2016-05-19 | Annual General meeting |
2016-05-17 | Quarterly Report 2016-Q1 |
2016-02-26 | Year-end Report 2015 |
2015-11-19 | Extra General Meeting 2015 |
2015-11-11 | Quarterly Report 2015-Q3 |
2015-08-17 | Quarterly Report 2015-Q2 |
2015-05-08 | Quarterly Report 2015-Q1 |
2015-04-10 | Ex-date Ordinary Dividend PMED 0.00 SEK |
2015-04-09 | Annual General meeting |
2015-02-27 | Year-end Report 2014 |
2014-10-15 | Quarterly Report 2014-Q3 |
2014-08-13 | Quarterly Report 2014-Q2 |
Description
Country | Sweden |
---|---|
List | Spotlight |
Sector | Health care |
Industry | Biotechnology |
2023-10-25 08:22:38
Peptonic Medical AB (publ) meddelade idag att VD Erik Sundquist intervjuats av Finwire.tv
Erik Sundquist intervjuas om Peptonic och bolagets framtid av Ludwig Sjöström på Finwire.tv. I intervjun samtalas det om bolagets portföljutveckling, samgåendet med Pharmiva samt planer för accelererad försäljningsutveckling under 2024. Välkommen att lyssna, för att komma direkt till intervjun klicka på länken nedan
https://www.youtube.com/watch?v=qgzPqDcTbAo
Erik Sundquist, VD
Telefon: + 46 722 49 90 43
E-post: erik.sundquist@peptonicmedical.se